[Therapy of radiation injuries of the bladder with orgotein (Peroxinom)].
30 patients who developed an irradiation bladder after radiotherapy of carcinoma uteri were treated with submucosal infiltration of orgotein. In this homogeneous series (same cancer, dosage and exposition of radiation, same sex) the success rate of 86% improvement of subjective symptoms or complete healing was excellent, not to be reached by any other mode of treatment. In one patient an anaphylactic shock was seen. Despite of this event--which happens in great published series in only 1 permille--orgotein infiltration should be the therapy of choice in actinic damaged urinary bladders.
Maier
U
U
Urologische Universitätsklinik Wien.
Zechner
O
O
D000283:Administration, Intravesical; D000328:Adult; D000368:Aged; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008667:Metalloproteins / Q000627:therapeutic use*; D008875:Middle Aged; D011832:Radiation Injuries / Q000188:drug therapy*; D011879:Radiotherapy Dosage; D001743:Urinary Bladder / Q000528:radiation effects*; D014594:Uterine Neoplasms / Q000532:radiotherapy*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D008667:Metalloproteins; C005180:orgotein
Therapie der Strahlenblase mit Orgotein (Peroxinom).